Samatasvir

CAS No. 1312547-19-5

Samatasvir( ATOLIHZIXHZSBA-BTSKBWHGSA-N | IDX719 )

Catalog No. M28765 CAS No. 1312547-19-5

Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 Get Quote
10MG 357 Get Quote
25MG 597 Get Quote
50MG 851 Get Quote
100MG 1152 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Samatasvir
  • Note
    Research use only, not for human use.
  • Brief Description
    Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
  • Description
    Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
  • In Vitro
    Samatasvir (IDX719) retains full activity in the presence of HIV and hepatitis B virus (HBV) antivirals and is not cross-resistant with HCV protease, nucleotide, and nonnucleoside polymerase inhibitor classes.
  • In Vivo
    ——
  • Synonyms
    ATOLIHZIXHZSBA-BTSKBWHGSA-N | IDX719
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1312547-19-5
  • Formula Weight
    885.07
  • Molecular Formula
    C47H48N8O6S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (56.49 mM)
  • SMILES
    COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1nc2ccc(cc2[nH]1)-c1csc2c(csc12)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@H](NC(=O)OC)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Casper DM, et al. Toward the development of a structurally novel class of chiral auxiliaries: diastereoselective aldol reactions of a (1R,2S)-ephedrine-based 3,4,5,6-tetrahydro-2H-1,3,4-oxadiazin-2-one. Org Lett. 2002 Oct 17;4(21):3739-42.
molnova catalog
related products
  • Voxilaprevir

    Voxilaprevir (GS-9857)?is a potent HCV NS3/4A protease inhibitor that is used in combination with sofosbuvir and velpatasvir for treatment of HCV infection.

  • Boceprevir

    A potent, selective, orally bioavailable HCV NS3 protease with Ki of 14 nM, EC90 of 350 nM in cell replicon assays.

  • Paritaprevir (b)

    Paritaprevir is a Hepatitis C Virus NS3/4A Protease Inhibitor.